Pharmaceutical care for a child with severe juvenile dermatomyositis
10.13699/j.cnki.1001-6821.2018.03.050
- VernacularTitle:1例重症幼年皮肌炎患儿的药学监护
- Author:
Zong-Yan LIU
1
;
Chao-Yang CHEN
;
Xiao-Yan XUE
;
Xian-Ting XIE
;
Ying ZHOU
;
Yi-Min CUI
Author Information
1. 北京大学第一医院药剂科
- Keywords:
immunoglobulin;
rituximab;
juvenile dermatomyositis;
pharmaceutical care
- From:
The Chinese Journal of Clinical Pharmacology
2018;34(3):353-355
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the role of clinical pharmacists in the pharmacological monitoring of children with severe juvenile dermatomyositis.Methods Clinical pharmacists participated in the formulation of treatment plans for a child with severe juvenile myositis.We monitored the curative effect of juvenile dermatomyositis treatment and anti-infec-tive treatment during therapy.We also monitored the condition of patient's liver function,renal function,electrolyte and infection,and proposed individualized drug administration advices according to patient's conditions.Results and conclusion The patient's condition was stable.The juvenile dermatomyositis treatment and anti-cryptococcus treatment were effective.Isotonic dehydration,hypocalcemia and hypokalemia were corrected.Liver function and renal function impairment were not aggravated.Clinical pharmacists participated in formulation of individualized treatment,and provided pharmaceutical care for children and medical workers,and promoted the safety,effectiveness and rationality of clinical therapy.
